Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: ARMHY is accumulating their own shares--and gave a divy - Jimbo

You say: "Also, on the topic of buying out the MMP (mentioned by SGE, I believe), remember that the entity is known as Phoenix Digital Solutions and, as such, I imagine it could be bought as a stand-alone entity, leaving Alliacense intact, TPL intact and PTSC intact, with TPL and PTSC sharing in the proceeds AFTER legal fees (which takes care of TT&C in a nice way, too.)."

Good point re: PDS. Thank you.  But I didn't mean "buy out Alliacense (PDS)", but that would be a result (i.e., the need for that entity would evaporate).  PDS does not own the patents. Nor does Alliacense. So the deal would have to directly involve PTSC and TPL, the patent owners. The way I see it, the best and easiest way to do this would be through an exclusive license.  It's probably not going to happen, but I'm suggesting that this would be the logical way for an entity to capture the MMP as opposed to covertly accumulating stock in PTSC.  This all part of my questioning "where's the threat?" if there were an accumulator.

SGE

Share
New Message
Please login to post a reply